128
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prognostic Factors and Construction of Nomogram Prediction Model of Lung Cancer Patients Using Clinical and Blood Laboratory Parameters

, , , , , , , & show all
Pages 131-144 | Received 25 Oct 2023, Accepted 31 Jan 2024, Published online: 20 Feb 2024

References

  • Inoue A, Johnson TF, Walkoff LA, et al. Lung cancer screening using clinical photon-counting detector computed tomography and energy-integrating-detector computed tomography: a prospective patient study. J Comput Assist Tomogr. 2022;47(2):229–235. PMID: 36573321. doi:10.1097/RCT.0000000000001419
  • Boulate D, Fidelle M, Caramella C, et al. Epidemiological study to assess the prevalence of lung cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol. BMJ Open. 2022;12(12):e067191. PMID: 36572501. doi:10.1136/bmjopen-2022-067191
  • Shao F, Ling L, Li C, et al. Establishing a metastasis-related diagnosis and prognosis model for lung adenocarcinoma through CRISPR library and TCGA database. J Cancer Res Clin Oncol. 2022. PMID: 36574046. doi:10.1007/s00432-022-04495-z
  • Yadav DK, Bhadresha K, Rao P, Shaikh S, Rawal RM. Identification of hub genes associated with prognosis of lung cancer via integrated bioinformatics and in vitro approach. J Biomol Struct Dyn. 2022;26:1–15. PMID: 36572419. doi:10.1080/07391102.2022.2160816
  • Devi-Marulkar P, Fastenackels S, Karapentiantz P, et al. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC. Commun Biol. 2022;5(1):1416. PMID: 36566320; PMCID: PMC9789959. doi:10.1038/s42003-022-04356-y
  • Zhang C, Shang X, Wang H. Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer. Metabolomics. 2022;19(1):3. PMID: 36574156. doi:10.1007/s11306-022-01964-x
  • Sathiyapalan A, Febbraro M, Pond GR, Ellis PM. Chemo-immunotherapy in first line Extensive Stage Small Cell Lung Cancer (ES-SCLC): a systematic review and meta-analysis. Curr Oncol. 2022;29(12):9046–9065. PMID: 36547123; PMCID: PMC9776593. doi:10.3390/curroncol29120709
  • Brisebarre A, Ancel J, Ponchel T, et al. Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer. Front Immunol. 2022;13:1058531. PMID: 36544755; PMCID: PMC9760670. doi:10.3389/fimmu.2022.1058531
  • Kawamoto N, Tsutani Y, Kamigaichi A, et al. Tumour Location Predicts Occult N1 Nodal metastasis in clinical stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2022:ezac575. PMID: 36571485. doi:10.1093/ejcts/ezac575
  • Cheng H, Bhushan S, Li N, Xiao Z, Gao K. Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor-node-metastasis stages in patients with non-small cell lung cancer. J Cancer Res Ther. 2022;18(6):1666–1673. PMID: 36412428. doi:10.4103/jcrt.jcrt_473_21
  • Mao JR, Lan KQ, Liu SL, et al. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission? Radiother Oncol. 2022;22:109445. PMID: 36566987. doi:10.1016/j.radonc.2022.109445
  • Zhang J, Xu L, Gao J, et al. Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma. Sci Rep. 2022;12(1):22201. PMID: 36564433; PMCID: PMC9789102. doi:10.1038/s41598-022-24183-9
  • Yin M, Guan S, Ding X, et al. Construction and validation of a novel web-based nomogram for patients with lung cancer with bone metastasis: a real-world analysis based on the SEER database. Front Oncol. 2022;12:1075217. PMID: 36568214; PMCID: PMC9780685. doi:10.3389/fonc.2022.1075217
  • Liu Z, Zhang R, Xv Y, Wang J, Chen J, Zhou X. A novel nomogram integrated with systemic inflammation markers and traditional prognostic factors for adverse events’ prediction in patients with chronic heart failure in the Southwest of China. J Inflamm Res. 2022;15:6785–6800. PMID: 36573109; PMCID: PMC9789703. doi:10.2147/JIR.S366903
  • Zhang H, Liao M, Guo Q, et al. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method. Med Phys. 2022. PMID: 36563341. doi:10.1002/mp.16177
  • Yang Z, Cai Y, Chen Y, et al. A CT-based radiomics nomogram combined with clinic-radiological characteristics for preoperative prediction of the novel IASLC grading of invasive pulmonary adenocarcinoma. Acad Radiol. 2022;23:S1076–S6332. PMID: 36567145. doi:10.1016/j.acra.2022.12.006
  • Isla D, Lozano MD, Paz-Ares L, et al. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2022. PMID: 36571695. doi:10.1007/s12094-022-03046-9
  • Ma L, Fang X, Zhang A. The hypermethylation of FOXP3 gene as an epigenetic marker for the identification of arsenic poisoning risk. Hum Exp Toxicol. 2022;41:9603271221142819. PMID: 36464704. doi:10.1177/09603271221142819
  • Zhao T, Zhao X, Qian K, Shi K, Gu Y, Zhang Y. Radiotherapy prognosis-associated gene GCNT3 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Heliyon. 2022;8(12):e12100. PMID: 36578381; PMCID: PMC9791338. doi:10.1016/j.heliyon.2022.e12100
  • Wang X, Zhang Y, Zhi X. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with non-small cell lung cancer: a retrospective study. Thorac Cancer. 2017;8(5):511–516. PMID: 28727276; PMCID: PMC5582486. doi:10.1111/1759-7714.12480
  • Huang H, Li L, Luo W, et al. Lymphocyte percentage as a valuable predictor of prognosis in lung cancer. J Cell Mol Med. 2022;26(7):1918–1931. PMID: 35122390; PMCID: PMC8980931. doi:10.1111/jcmm.17214
  • Ma B, Niu F, Qu X, et al. A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy. Biomaterials. 2019;204:1–12. PMID: 30861422; PMCID: PMC6441627. doi:10.1016/j.biomaterials.2019.03.004
  • Tomita M, Ayabe T, Maeda R, Nakamura K. The prognostic values of a novel preoperative inflammation-based score in Japanese patients with non-small cell lung cancer. World J Oncol. 2019;10(4–5):176–180. PMID: 31636791; PMCID: PMC6785273. doi:10.14740/wjon1222
  • Ichimura T, Ichikura D, Hinata M, Hida N, Baba T. Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: a case series. SAGE Open Med Case Rep. 2023;11:205. PMID: 37009547; PMCID: PMC10064459. doi:10.1177/2050313X231164488
  • Hojbjerg JA, Bentsen KK, Vinholt PJ, Hansen O, Jeppesen SS, Hvas AM. Increased in vivo thrombin generation in patients with localized non-small cell lung cancer unfit for surgery. Clin Appl Thromb Hemost. 2023;29:10760296231152897. PMID: 36802980; PMCID: PMC9941591. doi:10.1177/10760296231152897
  • Chen Z, Cai A, Zheng H, et al. Carbidopa suppresses prostate cancer via aryl hydrocarbon receptor-mediated ubiquitination and degradation of androgen receptor. Oncogenesis. 2020;9(5):49. PMID: 32404918; PMCID: PMC7220950. doi:10.1038/s41389-020-0236-x
  • Macek Jilkova Z, Aspord C, Decaens T. Predictive factors for response to PD-1/PD-L1 checkpoint inhibition in the field of hepatocellular carcinoma: current status and challenges. Cancers. 2019;11(10):1554. PMID: 31615069; PMCID: PMC6826488. doi:10.3390/cancers11101554
  • Morabito F, Adornetto C, Monti P, et al. Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy. Front Oncol. 2023;13:1198992. PMID: 37719021; PMCID: PMC10501728. doi:10.3389/fonc.2023.1198992
  • Hou F, Hou Y, Sun XD, et al. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study. PeerJ. 2023;11:e15678. PMID: 37456882; PMCID: PMC10349557. doi:10.7717/peerj.15678
  • Jin G, Hu W, Zeng L, et al. Development and verification of a nomogram for predicting short-term mortality in elderly ischemic stroke populations. Sci Rep. 2023;13(1):12580. PMID: 37537270. doi:10.1038/s41598-023-39781-4
  • Deng J, Fei Y, Huang B. Nomogram for predicting the recurrence rate in selective radiofrequency thermocoagulation of the trigeminal nerve based on regression via least absolute shrinkage and selection operator. Pain Physician. 2023;26(4):E341–E352. PMID: 37535781.
  • Clift AK, Dodwell D, Lord S, et al. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study. BMJ. 2023;381:e073800. PMID: 37164379; PMCID: PMC10170264. doi:10.1136/bmj-2022-073800
  • Chen L, Zhang Y, Yu C, et al.; China Kadoorie Biobank Collaborative Group. Modeling biological age using blood biomarkers and physical measurements in Chinese adults. EBioMedicine. 2023;89:104458. PMID: 36758480; PMCID: PMC9941058. doi:10.1016/j.ebiom.2023.104458
  • Lee S, Choi Y, Seo MK, et al. Magnetic resonance imaging-based radiomics for the prediction of progression-free survival in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancers. 2022;14(3):653. PMID: 35158921; PMCID: PMC8833585. doi:10.3390/cancers14030653
  • Liu L, Wang Z, Zhao L, Chen X, He S. External validation of non-invasive diabetes score in a 15-year prospective study. Am J Med Sci. 2022;364(5):624–630. PMID: 35640678. doi:10.1016/j.amjms.2022.05.023